Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$37.11 - $50.69 $975,993 - $1.33 Million
26,300 Added 68.31%
64,800 $3.12 Million
Q1 2024

May 07, 2024

SELL
$40.65 - $65.76 $1.81 Million - $2.93 Million
-44,600 Reduced 53.67%
38,500 $1.85 Million
Q4 2023

Feb 14, 2024

BUY
$48.3 - $68.06 $758,310 - $1.07 Million
15,700 Added 23.29%
83,100 $5.39 Million
Q3 2023

Nov 14, 2023

SELL
$54.2 - $71.67 $341,460 - $451,521
-6,300 Reduced 8.55%
67,400 $4.41 Million
Q2 2023

Aug 11, 2023

BUY
$56.23 - $71.17 $1.8 Million - $2.28 Million
32,100 Added 77.16%
73,700 $4.28 Million
Q1 2023

May 16, 2023

BUY
$53.43 - $68.12 $790,764 - $1.01 Million
14,800 Added 55.22%
41,600 $2.57 Million
Q4 2022

Feb 14, 2023

SELL
$61.23 - $83.62 $1.11 Million - $1.52 Million
-18,200 Reduced 40.44%
26,800 $1.7 Million
Q3 2022

Nov 14, 2022

BUY
$65.58 - $84.69 $1 Million - $1.3 Million
15,300 Added 51.52%
45,000 $3.27 Million
Q2 2022

Aug 15, 2022

SELL
$52.13 - $93.81 $6.72 Million - $12.1 Million
-128,900 Reduced 81.27%
29,700 $2.02 Million
Q1 2022

May 16, 2022

BUY
$64.92 - $99.47 $3.61 Million - $5.53 Million
55,600 Added 53.98%
158,600 $14.4 Million
Q4 2021

Feb 14, 2022

BUY
$76.51 - $93.96 $229,530 - $281,880
3,000 Added 3.0%
103,000 $9.4 Million
Q3 2021

Nov 15, 2021

BUY
$71.29 - $95.99 $2.12 Million - $2.86 Million
29,800 Added 42.45%
100,000 $8.11 Million
Q2 2021

Aug 11, 2021

BUY
$79.62 - $114.85 $772,314 - $1.11 Million
9,700 Added 16.03%
70,200 $6.55 Million
Q1 2021

May 17, 2021

BUY
$77.91 - $125.92 $70,119 - $113,328
900 Added 1.51%
60,500 $6.47 Million
Q4 2020

Feb 16, 2021

BUY
$60.0 - $87.29 $1.92 Million - $2.79 Million
32,000 Added 115.94%
59,600 $5.2 Million
Q3 2020

Nov 16, 2020

BUY
$47.53 - $82.76 $1.31 Million - $2.28 Million
27,600 New
27,600 $1.91 Million

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.17B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.